Gilead Sciences Ltd

Flowers Building, Granta Park, Abington, Cambridge, Cambridge, CB21 6GT, UK
Telephone: +44 (0)1223 897 300
Fax: +44 (0)1223 897 291
Medical Information Direct Line: +44 (0)1223 897 555
Medical Information e-mail: ukmedinfo@gilead.com
Customer Care direct line: +44 (0)1223 897 400
Medical Information Fax: +44 (0)1223 897 281

Patient Information Leaflet last updated on the eMC: 18/08/2011
PIL Emtriva 10 mg/ml oral solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 09/06/2011 and displayed until 18/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 14/09/2010 and displayed until 09/06/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to side-effects
Updated on 15/06/2009 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 05/01/2009 and displayed until 15/06/2009
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/06/2008 and displayed until 05/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 13/09/2007 and displayed until 09/06/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/03/2007 and displayed until 13/09/2007
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 05/03/2007 and displayed until 29/03/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/09/2006 and displayed until 05/03/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 04/05/2006 and displayed until 01/09/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 13/04/2006 and displayed until 04/05/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/06/2005 and displayed until 13/04/2006
Reasons for adding or updating:
  • Change to Further Information section
Updated on 24/02/2005 and displayed until 07/06/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   emtricitabine